Muscular dystrophy in mdx mice despite lack of neuronal nitric oxide synthase

Journal of Neurochemistry

Volumn 71, Issue 2, 1998, Pages 784-789

  Chao, Daniel S ^a   Silvagno, Francesca ^a   Bredt, David S ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Duchenne muscular dystrophy; mdx mice; Neuronal nitric oxide synthase

Indexed keywords

DYSTROPHIN; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; FEMALE; GENE DELETION; HISTOLOGY; MALE; MEMBRANE PERMEABILITY; MOUSE; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; SARCOLEMMA;

ANIMALIA;

EID: 0031755357     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.71020784.x     Document Type: Article

References (39)

1. Adams M. E., Butler M. H., Dwyer T. M., Peters M. F., Murnane A. A., and Froehner S. C. (1993) Two forms of mouse syntrophin. a 58 kd dystrophin-associated protein, differ in primary structure and tissue distribution. Neuron 11, 531-540.
2. Ahn A. H. and Kunkel L. M. (1993) The structural and functional diversity of dystrophin. Nat. Genet. 3, 283-291.
3. Balon T. W. and Nadler J. L. (1994) Nitric oxide release is present from incubated skeletal muscle preparations [see Comments]. J. Appl. Physiol. 77, 2519-2521.
4. Bertorini T. E., Bhattacharya S. K., Palmieri G. M., Chesney C. M., Pifer D., and Baker B. (1982) Muscle calcium and magnesium content in Duchenne muscular dystrophy. Neurology 32, 1088-1092.
5. Brenman J. E. and Bredt D. S. (1997) Synaptic signaling by nitric oxide. Curr. Opin. Neurobiol. 7, 374-378.
6. Brenman J. E., Chao D. S., Xia H., Aldape K., and Bredt D. S. (1995) Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 82, 743-752.
7. Brenman J. E., Chao D. S., Gee S. H.. McGee A. W., Craven S. E., Santillano D. R., Huang F., Xia H., Peters M. F., Froehner S. C., and Bredt D.S. (1996a) Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and α-1 syntrophin mediated by PDZ motifs. Cell 84, 757-767.
8. Brenman J. E., Christopherson K. S., Craven S. E., McGee A. W., and Bredt D. S. (1996b) Cloning and characterization of postsynaptic density 93 (PSD-93), a nitric oxide synthase interacting protein. J. Neurosci. 16, 7407-7415.
9. Brown R. H. (1995) Free radicals, programmed cell death and muscular dystrophy [Editorial]. Curr. Opin. Neural. 8, 373-378.
10. Bulfield G., Siller W. G., Wight P. A., and Moore K. J. (1984) X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc. Natl. Acad. Sci. USA 81, 1189-1192.
11. Campbell K. P. (1995) Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage. Cell 80, 675-679.
12. Chamberlain J. S., Phelps S. F., Cox G. A., Maichele A. J., and Greenwood A. D. (1993) PCR analysis of muscular dystrophy in mdx mice. Mol. Cell. Biol. Hum. Dis. Ser. 3, 167-189.
13. Chao D. S., Gorospe R. M., Brenman J. E., Rafael J. A., Peters M. F., Froehner S. C., Huffman E. P., Chamberlain J. S., and Bredt D. S. (1996) Selective loss of sarcolemmal nitric oxide synthase in Becker muscular dystrophy. J. Exp. Med. 184, 609-618.
14. Chao D. S., Silvagnano F., Cornwell T. L., Lincoln T. M., and Bredt D. S. (1997) Nitric oxide synthase and cyclic GMP-dependent protein kinase concentrated at neuromuscular endplates. Neuroscience 76, 665-672.
15. Dawson V. L. and Dawson T. M. (1996) Nitric oxide in neuronal degeneration. Proc. Soc. Exp. biol. Med. 211, 33-40.
16. Duggan D. J. and Hoffman E. P. (1996) Autosomal recessive muscular dystrophy and mutations of the sarcoglycan complex. Neuromuscul. Disord. 6, 475-482.
17. Edwards R. J. and Watts D. C. (1981) Specific spectrophotometric assay for the M isoenzymes of pyruvate kinase in plasma samples containing mixtures of the muscle (M) and liver (L) isoenzymes. Clin. Chem. 27, 906-909.
18. Gaschen F. P., Hoffman E. P., Gorospe J. R., Uhl E. W., Senior D. F., Cardinet G. H. D., and Pearce L. K. (1992) Dystrophin deficiency causes lethal muscle hypertrophy in cats. J. Neurol. Sci. 110, 149-159.
19. Griggs R. C., Mendell J. R., and Miller R. G. (1995) Evaluation and Treatment of Myopathies. F. A. Davis Company, Philadelphia.
20. Grinio L. P., Orlov O. N., Prilipko L. L., and Kagan V. E. (1984) Lipid peroxidation in children with Duchenne's hereditary myopathy. Biull. Eksp. Biol. Med. 98, 423-425.
21. Grozdanovic Z., Gosztonyi G., and Gossrau R. (1996) Nitric oxide synthase I (NOS-I) is deficient in the sarcolemma of striated muscle fibers in patients with Duchenne muscular dystrophy, suggesting an association with dystrophin. Acta Histochem. 98, 61-69.
22. Hantraye P., Brouillet E., Ferrante R., Palfi S., Dolan R., Matthews R. T., and Beal M. F. (1996) Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nat. Med. 2, 1017-1021.
23. Haycock J. W., MacNeil S., Jones P., Harris J. B., and Mantle D. (1996) Oxidative damage to muscle protein in Duchenne muscular dystrophy. Neuroreport 8, 357-361.
24. Hoffman E. P. and Kunkel L. M. (1989) Dystrophin abnormalities in Duchenne/Becker muscular dystrophy. Neuron 2, 1019-1029.
25. Hopf F. W., Turner P. R., Denetclaw W. F. Jr., Reddy P., and Steinhardt R. A. (1996) A critical evaluation of resting intracellular free calcium regulation in dystrophic mdx muscle. Am. J. Physiol. 271, C1325-C1339.
26. Huang P. L., Dawson T. M., Bredt D. S., Snyder S. H., and Fishman M. C. (1993) Targeted disruption of the neuronal nitric oxide synthase gene. Cell 75, 1273-1286.
27. Huang Z., Huang P. L., Panahian N., Dalkara T., Fishman M. C., and Moskowitz M. A. (1994) Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 265, 1883-1885.
28. Karpati G. and Carpenter S. (1986) Small-caliber skeletal muscle fibers do not suffer deleterious consequences of dystrophic gene expression. Am. J. Med. Genet. 25, 653-658.
29. Khurana T. S., Prendergast R. A., Alameddine H. S., Tome F. M., Fardeau M., Arahata K., Sugita H., and Kunkel L. M. (1995) Absence of extraocular muscle pathology in Duchenne's muscular dystrophy: role for calcium homeostasis in extraocular muscle sparing. J. Exp. Med. 182, 467-475.
30. Kobzik L., Reid M. B., Bredt D. S., and Stamler J. S. (1994) Nitric oxide in skeletal muscle. Nature 372, 546-548.
31. Kornegay J. N., Tuler S. M., Miller D. M., and Levesque D. C. (1988) Muscular dystrophy in a litter of golden retriever dogs. Muscle Nerve 11, 1056-1064.
32. Lee K. H., Baek M. Y., Moon K. Y., Song W. K., Chung C. H., Ha D. B., and Kang M. S. (1994) Nitric oxide as a messenger molecule for myoblast fusion. J. Biol. Chem. 269, 14371-14374.
33. McArdle A., Edwards R. H., and Jackson M. J. (1994) Time course of changes in plasma membrane permeability in the dystrophindeficient mdx mouse. Muscle Nerve 17, 1378-1384.
34. Monaco A. P., Neve R. L., Colletti-Feener C., Bertelson C. J., Kurnit D. M., and Kunkel L. M. (1986) Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature 323, 646-650.
35. Ohlendieck K., Matsumura K., Ionasescu V. V., Towbin J. A., Bosch E. P., Weinstein S. L., Sernett S. W., and Campbell K. P. (1993) Duchenne muscular dystrophy: deficiency of dystrophin-associated proteins in the sarcolemma. Neurology 43, 795-800.
36. Petrof B. J., Shrager J. B., Stedman H. H., Kelly A. M., and Sweeney H. L. (1993) Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc. Natl. Acad. Sci. USA 90, 3710-3714.
37. Silvagno F., Xia H., and Bredt D. S. (1996) Neuronal nitric oxide synthase-μ, an alternatively spliced isoform expressed in differentiated skeletal muscle. J. Biol. Chem. 271, 11204-11208.
38. Wang T., Xie Z., and Lu B. (1995) Nitric oxide mediates activity-dependent synaptic suppression at developing neuromuscular synapses. Nature 374, 262-266.
39. Watkins S. C., Hoffman E. P., Slayter H. S., and Kunkel L. M. (1989) Dystrophin distribution in heterozygote MDX mice. Muscle Nerve 12, 861-868.